Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as ...

Move positions company at the heart of Cambridge’s innovation ecosystem to accelerate growth and collaboration in infection prevention. CAMBRIDGE, MA / ACCESS Newswire / October 14, 2025 / Next Gen ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

PISCATAWAY, N.J., Oct. 14, 2025 /PRNewswire/ -- Sampled, a fully integrated analytical laboratory and biorepository, has partnered with AutoGen to provide advanced nucleic acid extraction and ...

SOUTH PLAINFIELD, NJ, UNITED STATES, November 5, 2024 /EINPresswire.com/ -- Admera Health, a leading Next-Generation Sequencing service provider, today announced its ...

Please provide your email address to receive an email when new articles are posted on . Real-world data show that only about 30% to 40% of patients with the most common cancers receive NGS testing.

The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology in ...

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

FORT DETRICK, Md. – Researchers at the U.S. Army Medical Research Institute of Infectious Diseases are testing a promising new biological threat detection method in high-fidelity training scenarios, ...

Because of tumor heterogeneity and sampling error, next-generation sequencing (NGS) of glioblastoma (GBM) tumors may provide an incomplete picture of the somatic mutational landscape. We hypothesized ...